ÂÜÀòÂÒÂ×

Matthew Dent, PhD has a diverse work experience in the scientific field. Matthew is currently working as a Scientist at iBio, Inc. since 2022. Prior to this, they held the position of Associate Scientist at the same company from February 2022 to January 2023. Before joining iBio, Inc., Matthew worked at The Biodesign Institute at Arizona State University as an Assistant Research Technologist from October 2015 to July 2016. In this role, they focused on developing a subunit vaccine for Zika Virus using E. coli expression and also trained new students. Matthew began their professional career as an Assistant Teaching Assistant at Arizona State University in August 2013, where they assisted in teaching responsibilities until December 2013.

Matthew Dent, PhD, has an extensive education history. Matthew began their academic journey in 2010 at Arizona State University, where they earned their Bachelor of Science (BS) degree in Molecular Biosciences and Biotechnology in 2014. Following this, they enrolled at The University of East Anglia and pursued their Master of Science (MSc) degree in Plant Genetics and Crop Development, which they completed in 2015.

In 2016, Dent continued their educational pursuits at the University of Louisville School of Medicine. Here, they obtained a Master of Science (MS) degree in Pharmacology and Toxicology in 2019, specializing in the field. Matthew then proceeded to pursue their Doctor of Philosophy (PhD) in Pharmacology and Toxicology at the same institution, which they successfully obtained in 2021.

Matthew Dent's education history showcases their dedication to the field of biosciences and their commitment to advancing their knowledge and expertise in pharmacology and toxicology through various degrees at renowned academic institutions.